EIF2S3B
gene geneOn this page
Also known as eIF2gAeIF-2-gamma2
Summary
EIF2S3B (eukaryotic translation initiation factor 2 subunit gamma B, HGNC:43863) is a protein-coding gene on chromosome 12p13.2, encoding Eukaryotic translation initiation factor 2 subunit 3B (Q2VIR3). Member of the eIF2 complex that functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA.
Predicted to enable translation initiation factor activity. Predicted to contribute to tRNA binding activity. Predicted to be involved in formation of translation preinitiation complex. Predicted to act upstream of or within positive regulation of male gonad development and spermatogenesis. Predicted to be part of eukaryotic translation initiation factor 2 complex.
Source: NCBI Gene 255308 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001357734
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43863 |
| Approved symbol | EIF2S3B |
| Name | eukaryotic translation initiation factor 2 subunit gamma B |
| Location | 12p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | eIF2gA, eIF-2-gamma2 |
| Ensembl gene | ENSG00000180574 |
| Ensembl biotype | protein_coding |
| Entrez | 255308 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000322446, ENST00000538173
RefSeq mRNA: 2 — MANE Select: NM_001357734
NM_001357731, NM_001357734
CCDS: CCDS86282, CCDS91654
Canonical transcript exons
ENST00000538173 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002304914 | 10505890 | 10508525 |
Expression profiles
Bgee: expression breadth ubiquitous, 103 present calls, max score 82.04.
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.04 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.99 | gold quality |
| stromal cell of endometrium | CL:0002255 | 59.22 | gold quality |
| cortical plate | UBERON:0005343 | 57.92 | gold quality |
| bone marrow cell | CL:0002092 | 57.84 | silver quality |
| duodenum | UBERON:0002114 | 57.36 | gold quality |
| ventricular zone | UBERON:0003053 | 56.77 | gold quality |
| testis | UBERON:0000473 | 54.67 | gold quality |
| right testis | UBERON:0004534 | 54.59 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 53.12 | gold quality |
| left testis | UBERON:0004533 | 53.11 | gold quality |
| ganglionic eminence | UBERON:0004023 | 52.71 | gold quality |
| bone marrow | UBERON:0002371 | 52.51 | silver quality |
| rectum | UBERON:0001052 | 51.63 | gold quality |
| muscle tissue | UBERON:0002385 | 50.32 | gold quality |
| transverse colon | UBERON:0001157 | 48.70 | gold quality |
| colonic epithelium | UBERON:0000397 | 48.44 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 46.97 | silver quality |
| urinary bladder | UBERON:0001255 | 46.85 | gold quality |
| leukocyte | CL:0000738 | 46.19 | gold quality |
| lymph node | UBERON:0000029 | 46.15 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 46.11 | silver quality |
| prefrontal cortex | UBERON:0000451 | 45.70 | gold quality |
| colon | UBERON:0001155 | 44.94 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 44.76 | gold quality |
| intestine | UBERON:0000160 | 44.73 | gold quality |
| monocyte | CL:0000576 | 44.57 | gold quality |
| vermiform appendix | UBERON:0001154 | 44.41 | gold quality |
| small intestine | UBERON:0002108 | 44.13 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 43.98 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.58 |
Regulation
Is transcription factor: no
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | eif2s3 | ENSDARG00000008292 |
| mus_musculus | Eif2s3x | ENSMUSG00000035150 |
| rattus_norvegicus | Eif2s3y | ENSRNOG00000060048 |
| drosophila_melanogaster | mEFTu2 | FBGN0033184 |
| drosophila_melanogaster | eIF2gamma | FBGN0263740 |
| caenorhabditis_elegans | tufm-2 | WBGENE00007001 |
| caenorhabditis_elegans | eif-2gamma | WBGENE00021466 |
Paralogs (18): MTIF2 (ENSG00000085760), GTPBP1 (ENSG00000100226), EEF1A2 (ENSG00000101210), GSPT1 (ENSG00000103342), EFTUD2 (ENSG00000108883), HBS1L (ENSG00000112339), EIF2S3 (ENSG00000130741), EEFSEC (ENSG00000132394), EFL1 (ENSG00000140598), GUF1 (ENSG00000151806), EEF1A1 (ENSG00000156508), EIF5B (ENSG00000158417), GFM2 (ENSG00000164347), EEF2 (ENSG00000167658), GFM1 (ENSG00000168827), GTPBP2 (ENSG00000172432), TUFM (ENSG00000178952), GSPT2 (ENSG00000189369)
Protein
Protein identifiers
Eukaryotic translation initiation factor 2 subunit 3B — Q2VIR3 (reviewed: Q2VIR3)
Alternative names: Eukaryotic translation initiation factor 2 subunit gamma A
All UniProt accessions (1): Q2VIR3
UniProt curated annotations — full annotation on UniProt →
Function. Member of the eIF2 complex that functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA. This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form the 43S pre-initiation complex (43S PIC). Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF2 and release of an eIF2-GDP binary complex. In order for eIF2 to recycle and catalyze another round of initiation, the GDP bound to eIF2 must exchange with GTP by way of a reaction catalyzed by eIF-2B.
Subunit / interactions. eIF2 is a heterotrimer composed of an alpha, a beta and a gamma chain. eIF2 is member of the 43S pre-initiation complex (43S PIC).
Tissue specificity. Specifically expressed in testis at the mRNA level.
Similarity. Belongs to the TRAFAC class translation factor GTPase superfamily. Classic translation factor GTPase family. EIF2G subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q2VIR3-1 | 1 | yes |
| Q2VIR3-2 | 2 |
RefSeq proteins (2): NP_001344660, NP_001344663* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000795 | T_Tr_GTP-bd_dom | Domain |
| IPR004161 | EFTu-like_2 | Domain |
| IPR009000 | Transl_B-barrel_sf | Homologous_superfamily |
| IPR009001 | Transl_elong_EF1A/Init_IF2_C | Homologous_superfamily |
| IPR015256 | eIF2g_C | Domain |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR044127 | eIF2g_dom_2 | Domain |
| IPR044128 | eIF2g_GTP-bd | Domain |
| IPR050543 | eIF2G | Family |
Pfam: PF00009, PF03144, PF09173
Catalyzed reactions (Rhea), 1 shown:
- GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)
UniProt features (21 total): sequence conflict 7, region of interest 5, binding site 3, modified residue 2, initiator methionine 1, chain 1, splice variant 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2VIR3-F1 | 85.40 | 0.39 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (3): 225–227; 51–56; 190–193
Post-translational modifications (2): 2, 16
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 21 (showing top):
GOBP_CYTOPLASMIC_TRANSLATION, GOBP_TRANSLATIONAL_INITIATION, GOMF_TRANSLATION_INITIATION_FACTOR_ACTIVITY, GOBP_TRANSLATION, GOBP_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX, GOBP_CYTOPLASMIC_TRANSLATIONAL_INITIATION, GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOMF_GTPASE_ACTIVITY, GOMF_TRNA_BINDING, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES, GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2_COMPLEX, DESCARTES_MAIN_FETAL_ELF3_AGBL2_POSITIVE_CELLS, GOMF_GUANYL_NUCLEOTIDE_BINDING, LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_DN
GO Biological Process (3): formation of translation preinitiation complex (GO:0001731), translation (GO:0006412), translational initiation (GO:0006413)
GO Molecular Function (6): tRNA binding (GO:0000049), translation initiation factor activity (GO:0003743), GTPase activity (GO:0003924), GTP binding (GO:0005525), nucleotide binding (GO:0000166), hydrolase activity (GO:0016787)
GO Cellular Component (1): eukaryotic translation initiation factor 2 complex (GO:0005850)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| translational initiation | 2 |
| cytoplasmic translational initiation | 1 |
| protein-RNA complex assembly | 1 |
| peptidyltransferase activity | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| formation of translation initiation ternary complex | 1 |
| translation | 1 |
| metabolic process | 1 |
| RNA binding | 1 |
| translation factor activity | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| catalytic activity | 1 |
| cytoplasm | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
16 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| TK2 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| JUN | TPM3 | psi-mi:“MI:0914”(association) | 0.350 |
| DLD | NFKBIE | psi-mi:“MI:0914”(association) | 0.350 |
| DNM1L | psi-mi:“MI:0914”(association) | 0.350 | |
| DLD | IRS4 | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| TAGLN | LOC392647 | psi-mi:“MI:0914”(association) | 0.350 |
| BMI1 | MEIS3P1 | psi-mi:“MI:0914”(association) | 0.350 |
| RYBP | PIPSL | psi-mi:“MI:0914”(association) | 0.350 |
| AFG2A | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| NSS | DDX3X | psi-mi:“MI:0914”(association) | 0.350 |
| CDC5L | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A1L8EV45, C9WPN6, F1QGW6, F6RQL9, O73723, O77676, P00516, P0C605, P20461, P23258, P23330, P31321, P32392, P35250, P41091, P53033, P61157, P61158, P62482, P62483, P81795, P83887, P83888, Q05B83, Q0VCD2, Q13126, Q13303, Q13976, Q27955, Q2KHU8, Q2KJ81, Q2VIR3, Q32KM1, Q4V7C7, Q5R797, Q5R8R1, Q5ZHS1, Q5ZMS3, Q641P0, Q641W4
Diamond homologs: A1AVJ8, A1AX82, A1UBL1, A2BT83, A3CP09, A3PV96, A4FPM7, A4FWW9, A4VTQ7, A4VZZ3, A5CW32, A5GIP0, A5GW14, A6UPK8, A6UTL4, A6VGE8, A7HWP7, A8AWA0, A9AAA4, A9BCK0, B0R6Y7, B1ICR4, B1MGH7, B1VET1, B5E653, B6YW69, B8ZL95, B9DRL9, B9LSM6, C1C881, C1CF71, C1CLI6, C1CSB0, C9WPN6, F1QGW6, J9VR81, O26361, O29663, O36041, O59410
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
139 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:10506870:C:CA | acceptor_gain | 0.6500 |
| 12:10506729:G:T | donor_gain | 0.5600 |
| 12:10506745:T:TA | donor_gain | 0.5600 |
| 12:10506746:A:AA | donor_gain | 0.5600 |
| 12:10506862:A:AG | acceptor_gain | 0.5300 |
| 12:10506728:G:GT | donor_gain | 0.5000 |
| 12:10506743:GGT:G | donor_gain | 0.4900 |
| 12:10507037:A:AG | acceptor_gain | 0.4700 |
| 12:10507038:G:GG | acceptor_gain | 0.4700 |
| 12:10506734:GT:G | donor_gain | 0.4300 |
| 12:10506870:CGG:C | acceptor_gain | 0.4300 |
| 12:10506878:A:AG | acceptor_gain | 0.4100 |
| 12:10507037:AGACG:A | acceptor_gain | 0.4100 |
| 12:10507038:GACGG:G | acceptor_gain | 0.4100 |
| 12:10506729:G:GT | donor_gain | 0.4000 |
| 12:10506871:G:A | acceptor_gain | 0.4000 |
| 12:10507036:TAGAC:T | acceptor_gain | 0.4000 |
| 12:10506002:G:GT | donor_gain | 0.3900 |
| 12:10506788:G:GG | donor_gain | 0.3900 |
| 12:10506605:GTTT:G | donor_gain | 0.3800 |
| 12:10506787:A:AG | donor_gain | 0.3800 |
| 12:10506863:C:G | acceptor_gain | 0.3600 |
| 12:10506747:G:GG | donor_gain | 0.3500 |
| 12:10505976:TTACC:T | donor_gain | 0.3300 |
| 12:10506277:A:G | donor_gain | 0.3300 |
| 12:10506448:G:GT | donor_gain | 0.3300 |
| 12:10506872:G:C | acceptor_gain | 0.3300 |
| 12:10507038:GAC:G | acceptor_gain | 0.3300 |
| 12:10506006:T:G | donor_gain | 0.3200 |
| 12:10506554:G:GT | donor_gain | 0.3200 |
AlphaMissense
3065 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:10506044:G:C | G48R | 1.000 |
| 12:10506045:G:A | G48D | 1.000 |
| 12:10506045:G:T | G48V | 1.000 |
| 12:10506050:G:C | V50L | 1.000 |
| 12:10506050:G:T | V50L | 1.000 |
| 12:10506059:G:T | G53W | 1.000 |
| 12:10506060:G:A | G53E | 1.000 |
| 12:10506062:A:C | K54Q | 1.000 |
| 12:10506063:A:T | K54I | 1.000 |
| 12:10506066:C:T | S55F | 1.000 |
| 12:10506147:G:A | G82E | 1.000 |
| 12:10506300:T:A | V133D | 1.000 |
| 12:10506302:G:C | D134H | 1.000 |
| 12:10506303:A:C | D134A | 1.000 |
| 12:10506303:A:T | D134V | 1.000 |
| 12:10506305:T:C | C135R | 1.000 |
| 12:10506306:G:A | C135Y | 1.000 |
| 12:10506307:T:G | C135W | 1.000 |
| 12:10506309:C:A | P136H | 1.000 |
| 12:10506311:G:C | G137R | 1.000 |
| 12:10506311:G:T | G137C | 1.000 |
| 12:10506312:G:A | G137D | 1.000 |
| 12:10506312:G:T | G137V | 1.000 |
| 12:10506314:C:G | H138D | 1.000 |
| 12:10506315:A:G | H138R | 1.000 |
| 12:10506316:C:A | H138Q | 1.000 |
| 12:10506316:C:G | H138Q | 1.000 |
| 12:10506318:A:T | D139V | 1.000 |
| 12:10506324:T:C | L141S | 1.000 |
| 12:10506327:T:A | M142K | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000030104 (12:10523302 A>G), RS1000102923 (12:10513523 T>C,G), RS1000337608 (12:10511100 C>G,T), RS1000373401 (12:10510727 C>T), RS1000550424 (12:10510411 A>G), RS1000653811 (12:10523036 G>A), RS1001320762 (12:10520162 A>C), RS1001335246 (12:10515663 G>A), RS1001372698 (12:10520639 T>C), RS1001508008 (12:10504096 A>G), RS1001704713 (12:10521707 A>C), RS1001994644 (12:10513409 T>C), RS1002011719 (12:10509455 T>G), RS1002044153 (12:10509205 T>A), RS1002225905 (12:10508668 C>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Arsenic Trioxide | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Tretinoin | affects cotreatment, decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.